Larry Cohler, MD, PhD, FACS

Dr. Larry Cohler is board certified in thoracic and cardiac surgery. He is a staff surgeon at saint Agnes Medical Center, Fresno Heart & Surgical Center and Community Medical Center.



  • Ph. D., Physiology  May 21, 1987, Albany Medical College of Union University Department of Physiology,  Albany, New York
  • Doctor of Medicine, May 16, 1981, University of Iowa College of Medicine, Iowa City, Iowa
  • Bachelor of Science, June 9, 1976, McGill University, 845 Sherbrooke Street West, Montreal, Quebec  H3A 2T5 Canada

General Educational Training

  • University of Southern California Medical Center 1981-1982  Internship PGY I General Surgery, Los Angeles, California
  • University of California – Irvine Medical Center 1982-1983  Resident PGY II General Surgery, Orange, California
  • Albany Medical College of Union University Dept. of Physiology 1983-1986  NIH Postdoctoral Research Fellow, Albany, New York
  • Albany Medical Center 1986-1988  Resident PGY III – V General Surgery, Albany, New York
  • University of California – San Francisco Medical Center 1989-1991 Resident Thoracic Surgery, San Francisco, California
  • Northwestern Memorial Hospital Division of Cardiac Surgery 2010- 2011  Advanced Adult Cardiac Surgery Fellow, Chicago, Illinois


  • Member-Western Thoracic Surgical Association 2008-present
  • Fellow-American College of Surgeons 2001-present
  • Member-Bay Area Society of Thoracic Surgeons (California) 2000-present
  • Member-Society of Thoracic Surgeons 2000-present
  • Member-American Medical Association 1991-1994 & 2004-2006
  • Member-California Medical Association 1992-1994 & 1996-1997
  • Trustee-Clark County (NV) Medical Society 2003-2006
  • Member-Nevada State Medical Association 1999-2009
  • Member-Clark County (NV) Medical Society 1999-2009
  • Member-Pima County (AZ) Medical Society 1998-1999
  • Member-Santa Cruz (CA) Medical Society 1996-1997
  • Member-San Diego County (CA) Medical Society 1992-1994
  • Associate Fellow-American College of Surgeons 1991-1994

Board Certification

  • American Board of Surgery
  • American Board of Thoracic Surgery


  • Arizona
  • California
  • Illinois
  • Nevada
  • New Mexico
  • Wisconsin

Professional Appointment

  • Valley Cardiac Surgery Medical Group, Employee 2011-Present
  • Clovis Community Medical Center, 2011-present
  • Community Regional Medical Center, University of Calif. San Francisco – Fresno 2011-present
  • Fresno Heart and Surgical Hospital, 2011-present
  • St. Agnes Hospital and Medical Center, 2011-present
  • Co-Medical Director, Cardiac Surgery Program Kingman Regional Medical Center, Kingman, Arizona 2009-2010
  • Chairman, Dept. of Surgery Desert Springs Hospital and Medical Center, Las Vegas, Nevada 2007-2009
  • Chairman, Dept. of Surgery Valley Hospital and Medical Center, Las Vegas, Nevada 2006-2007
  • Chief, Division of Cardiovascular Surgery Spring Valley Hospital & Medical Center, Las Vegas, Nevada  2005-2007
  • Chief, Division of Cardiovascular Surgery Sunrise Hospital and Medical Center, Las Vegas, Nevada 2000-2004
  • Clinical Instructor of Surgery Department of Surgery Division of Cardiothoracic Surgery University of Nevada – Las Vegas School of Medicine, Las Vegas, Nevada 2003-2009
  • Clinical Assistant Professor of Surgery Department of Surgery Division of Cardiothoracic Surgery University of Nevada – Las Vegas School of Medicine, Las Vegas, Nevada 2000-2002


  • “New Concepts in Endoscopic Surgery”  American Association of Operating Room Nurses, Las Vegas, Nevada.  September 2006
  • “Appearance of fibronectin fragments in sheep lung lymph with Pseudomonas bacteremia.”  American Physiology Society, San Diego, California.  October 1987
  • “Attenuation of lung protein clearance during Pseudomonas bacteremia by infusion of purified and pasteurized human plasma fibronectin.” American Physiology Society, New Orleans, Louisiana.  October 1986
  • “Relationship of plasma fibronectin to lung protein clearance in sheep with Pseudomonas bacteremia.”  Federation of the American Society of Experimental Biology, St. Louis, Missouri. April 1986
  • “Does fibronectin modulate protease induced pulmonary vascular permeability?”  The Seventh Annual Conference on Shock, The Shock Society, Toronto, Ontario, Canada.  June 1984



  • Cohler, L.F., Saba, T.M. and Lewis, E.P., Vincent, P.A. and Charash, W.E. : Plasma fibronectin and lung transvascular protein clearance with gram-negative bacteremia:Response to fibronectin therapy. J. Appl. Physio. 63:623-633, 1987
  • Cohler, L.F., Saba, T.M. and Lewis, E.P. : Lung vascular injury with protease infusion: Relationship to plasma fibronectin. Ann. Surg 202:240-247, 1985
  • Saba, T.M., Cohler, L.F., Daudi, I. : Plasma fibronectin: Its potential therapeutic value to the critically ill patient, In The Pharmacologic Approach to the Critically Ill Patient. (B. Chernow, editor), Williams & Wilkins, pp, 780-793, (invited review)


  • Cohler, L.F., Saba, T.M., Lewis, E.P., Vincent, P.A. and Blumenstock, F.A. : Effect of human plasma fibronectin infusion on lung vascular permeability during bacteremia. Physiologist 30:144, 1987
  • Cohler, L.F., Saba, T.M., Lewis, E.P. and Vincent, P.A. : Lung vascular permeability with I.V. Pseudomonas: Relationship to fibronectin. Fed. Proc. 45:400, 1986
  • Cohler, L.F., Vincent, P.A., Lewis, E.P. and Saba, T.M. : Pulmonary vascular injury with protease infusion: Does plasma fibronectin have a modulating role? Circ. Shock. 13:88, 1984

Specialty Areas of Practice

  • Adult Cardiac Surgery
  • Endoscopic Thoracic Surgery
  • Endovascular treatment of thoracic and aortic aneurysms
  • Hemodialysis Access with special interest and participation in the “Fistula First” and “Conversion to Fistula” initiative since its national inception
  • Peripheral Vascular Surgery
  • Thoracic Surgery